The Aerobika(R) Device, Marketed by Monaghan Medical in the United States, Benefits COPD Patients and Wins Gold at MDEA Awards
The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the Medical Design Excellence Awards (MDEA).
Plattsburgh, NY, USA (July 17, 2014) - The Aerobika® Oscillating Positive Expiratory Pressure (OPEP) Therapy System marketed by Monaghan Medical Corporation has earned Gold at the Medical Design Excellence Awards (MDEA). MDEA is an International Award recognizing groundbreaking products that save lives, improve patient healthcare, change the face of medical technology, and overcome design and engineering challenges. It is one of the medical technology industry's highest honors. The Aerobika® Oscillating PEP device is a drug-free, easy to use, hand-held device that helps people with COPD, Cystic Fibrosis (CF) and other respiratory conditions to breathe easier and live better. COPD (Chronic Obstructive Pulmonary Disease) is the fourth leading cause of death globally and continues to grow in prevalence. Clinical evaluations conducted at Robarts Research Institute (Western University, London) demonstrated use of the device could significantly reduce breathlessness and improve patient's quality of life.
"When the Aerobika® Oscillating PEP Therapy System was created, the goal was to develop a product that addressed an unmet need for patients suffering from serious respiratory conditions, including COPD, CF, Bronchiectasis, Post Op and any patient with a productive cough requiring a non - pharmaceutical method to assist removing secretions from the lung. The innovation built into the Aerobika® OPEP device delivers excellent effectiveness while being very easy to use," states Dom Coppolo, Vice President of Clinical Affairs at Monaghan Medical Corporation. "The overall goal of the device is to ensure the patient can maintain their treatments to control their...
Please join StudyMode to read the full document